Published December 1987
| Version v1
Journal article
Synthesis of 3H- and 14C-cisapride
- 1. Janssen Pharmaceutica, Beerse (Belgium). Dept. of Drug Metabolism and Pharmacokinetics
Description
Cisapride, (±)-cis-4-amino-5-chloro-N[1-[3(4-fluorophenoxy) propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide, is a new gastrokinetic drug with a potent stinulating effect on the gastrointestinal motor activity. Metabolic studies required the synthesis of cisapride labelled at one of the three major moieties. Hence, cisapride was tritiated either in the fluorophenyl moiety by means of reductive dehalogenation, or via reductive amination in the piperidine ring. 14C-Cisapride was labelled in the benzamide function. The title compounds were obtained at a specific activity of 17.0 ci/mmol, 59.8 mCi/mmol and 7.8 mCi/mmol, respectively and with HPLC purities of > 98 %. (author)
Additional details
Publishing Information
- Journal Title
- J. Labelled Compd. Radiopharm.
- Journal Volume
- 24
- Journal Issue
- 12
- Series
- J. Labelled Compd. Radiopharm.
- Journal Page Range
- 1493-1501
- ISSN
- 0362-4803
- CODEN
- JLCRD
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- United Kingdom
- INIS RN
- 19057820
- Subject category
- S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Descriptors DEI
- AMINATION; CARBON 14 COMPOUNDS; CHEMICAL PREPARATION; DEHALOGENATION; GASTROINTESTINAL TRACT; LABELLING; ORGANIC FLUORINE COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; RADIOPHARMACEUTICALS; TRITIUM COMPOUNDS
- Descriptors DEC
- CARBON COMPOUNDS; CHEMICAL REACTIONS; DIGESTIVE SYSTEM; DRUGS; HYDROGEN COMPOUNDS; LABELLED COMPOUNDS; MATERIALS; ORGANIC COMPOUNDS; ORGANIC HALOGEN COMPOUNDS; RADIOACTIVE MATERIALS; SYNTHESIS